Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Characterization of the yehUT Two-Component Regulatory System of Salmonella enterica Serovar Typhi and Typhimurium

  • Vanessa K. Wong,

    Affiliations Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom, University of Cambridge Department of Pathology, Addenbrooke's Hospital, Cambridge, United Kingdom

  • Derek J. Pickard,

    Affiliation Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom

  • Lars Barquist,

    Affiliations Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom, European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom

  • Karthikeyan Sivaraman,

    Affiliations European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom, Positive Bioscience Ltd, Mumbai, India

  • Andrew J. Page,

    Affiliation Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom

  • Peter J. Hart,

    Affiliation Medical Research Council Centre for Immune Regulation and Clinical Immunology Service, Institute of Biomedical Research, School of Immunity and Infection, College of Medicine and Dental Sciences, University of Birmingham, Birmingham, United Kingdom

  • Mark J. Arends,

    Affiliations University of Cambridge Department of Pathology, Addenbrooke's Hospital, Cambridge, United Kingdom, University of Edinburgh Division of Pathology, Edinburgh Cancer Research Centre, Institute of Genetics & Molecular Medicine, Western General Hospital, Edinburgh, United Kingdom

  • Kathryn E. Holt,

    Affiliation Department of Biochemistry and Molecular Biology and Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Australia

  • Leanne Kane,

    Affiliation Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom

  • Lynda F. Mottram,

    Affiliations Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom, Novartis Vaccines Institute for Global Health, Siena, Italy

  • Louise Ellison,

    Affiliation Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom

  • Ruben Bautista,

    Affiliation Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom

  • Chris J. McGee,

    Affiliation Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom

  • Sally J. Kay,

    Affiliation Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom

  • Thomas M. Wileman,

    Affiliation Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom

  • Linda J. Kenney,

    Affiliations Mechanobiology Institute, National University of Singapore, T-Lab, Singapore, Singapore, Department of Microbiology and Immunology (M/C 790), University of Illinois at Chicago, Chicago, Illinois, United States of America

  • Calman A. MacLennan,

    Affiliations Medical Research Council Centre for Immune Regulation and Clinical Immunology Service, Institute of Biomedical Research, School of Immunity and Infection, College of Medicine and Dental Sciences, University of Birmingham, Birmingham, United Kingdom, Novartis Vaccines Institute for Global Health, Siena, Italy

  • Robert A. Kingsley ,

    rak@sanger.ac.uk

    Affiliation Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom

  •  [ ... ],
  • Gordon Dougan

    Affiliation Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom

  • [ view all ]
  • [ view less ]

Abstract

Proteins exhibiting hyper-variable sequences within a bacterial pathogen may be associated with host adaptation. Several lineages of the monophyletic pathogen Salmonella enterica serovar Typhi (S. Typhi) have accumulated non-synonymous mutations in the putative two-component regulatory system yehUT. Consequently we evaluated the function of yehUT in S. Typhi BRD948 and S. Typhimurium ST4/74. Transcriptome analysis identified the cstA gene, encoding a carbon starvation protein as the predominantly yehUT regulated gene in both these serovars. Deletion of yehUT had no detectable effect on the ability of these mutant Salmonella to invade cultured epithelial cells (S. Typhi and S. Typhimurium) or induce colitis in a murine model (S. Typhimurium only). Growth, metabolic and antimicrobial susceptibility tests identified no obvious influences of yehUT on these phenotypes.

Introduction

Enteric bacteria have evolved a complex lifestyle involving survival in a variety of niches, including the environment and the intestinal lumen of various animal species. Therefore bacteria must regulate global gene expression in response to their environment, gathering information in part through specialized two-component regulatory systems that sense environmental changes. These systems largely operate by exploiting signal-sensing domains on histidine kinase (HK) sensory proteins linked to cognate response regulators (RR) that can modulate gene expression [1]. The regulons associated with many two-component systems have been defined and in some cases some of their environmental stimuli elucidated [2]. However, others remain poorly characterized.

Orthologues of the candidate two-component regulatory system yehUT are found in almost all enteric bacteria, including plant and animal pathogens [3]. Detectable autophosphorylation of YehU and phosphotransfer to YehT has been shown to occur in Escherichia coli [4]. In E. coli, yehUT regulates yjiY, a gene that encoded an inner membrane protein belonging to the carbon starvation protein superfamily. yehUT may be involved in the stationary phase control network as YjiY is strongly induced at the onset of this growth phase [3]. However, detailed phenotypic analysis of derivatives harboring mutations in the yehUT system identified no other obvious differences with otherwise isogenic wild type E. coli [3,5]. However, overexpression of yehT in E. coli conferred resistance to compounds such as crystal violet, deoxycholate [6], and beta-lactam antibiotics [7].

Salmonella enterica serovar Typhi (S. Typhi) is a human restricted enteric bacterial pathogen that causes typhoid [8]. S. Typhi is a monophyletic pathogen that likely crossed into the human population once thousands of years ago [9]. Thus, all S. Typhi have a common ancestor and genetic variation in this pathogen is limited and largely characterized by extensive loss of gene function in the form of pseudogene accumulation [10]. Pseudogenes are defined as genes that are potentially inactivated by mutations including nonsense single nucleotide polymorphisms (SNPs), frame-shifts and truncation by deletion or rearrangement [10-13]. Whole genome sequence of multiple S. Typhi isolates has revealed its remarkable clonal nature with very few non-synonymous SNPs [9,10]. However, Holt et al. [10] identified several genes containing more than six substitutions when compared to the S. Typhi CT18 genome, deviating from the expected Poisson distribution in terms of the accumulation of non-synonymous SNPs, and these proteins may therefore be under selection. In S. Typhi, the yehUT operon has accumulated relatively more non-synonymous mutations in a number of lineages of the phylogenetic tree compared to other genes, suggesting this operon is potentially undergoing adaptive evolution [9,10]. These observations stimulated us to conduct a more in depth investigation of the yehUT loci in an attempt to identify a phenotype in Salmonella.

Materials and Methods

Ethics

Ethical approval for the use of serum samples in this study was granted by the Life and Health Sciences Ethical Review Committee of the University of Birmingham, UK. Informed written consent was obtained from all participants.

For the mouse experiments wild type C57BL/6 mice 8-10 weeks of age were maintained according to UK Home Office Animals (Scientific Procedures) Act 1986 Amendment Regulations 2012 and the Code of Practice for the housing and care of animals used in scientific procedures. The protocols (Home Office Project licence number: 80/2596) were approved by the Animal Welfare and Ethical Review Body at the Wellcome Trust Sanger Institute. Surgery was performed under isofluorane anaesthesia to eliminate suffering.

Bacteria used for mutant construction

For safety reasons an attenuated derivative of S. Typhi Ty 2 (BRD948 ΔaroA, ΔaroC, ΔhtrA) was used throughout as the parental isolate for the construction of mutant derivatives [14]. S. Typhimurium ST4/74, originally isolated from a calf with salmonellosis, was used as the parent strain for mutant derivative construction [15].

Informatics analyses

The domain architecture of YehU/YehT was analyzed using InterPro [16]. Transmembrane alpha helical segments were predicted with the TMHMM webserver [17]. The yehUT genes of S. Typhi Ty2 (Accession number AE014613) and S. Typhimurium SL1344 (Accession number FQ312003) were analyzed using the Genome browser Artemis [18]. The ST4/74 strain is the older designation of SL1344 [19]. The analysis required a completed genome sequence with annotation that is available for SL1344 (Accession number FQ312003), but not strictly for ST4/74. The amino acid sequences of YehU/YehT between S. Typhi Ty2 (Accession number AE014613) and S. Typhimurium SL1344 (Accession number FQ312003) were compared using ClustalW2 [20,21]. The YehU/YehT protein sequences were also compared with the two-component regulatory system of EnvZ/OmpR using ClustalW2 [20,21]. Non-synonymous SNPs in the yehUT genes of S. Typhimurium SL1344 (Accession number FQ312003) were identified by comparison to S. Typhi CT18 (Accession number: AL513382) using ClustalW2 [20,21].

Growth conditions

Experimental analysis determined that yehU was expressed during growth in minimal media, pH 7.0, with glucose or acetate as a carbon source (Accession number GSE2456). Therefore, for the SDS-PAGE and Western blot analysis S. Typhi, S. Typhimurium and their mutant derivatives were grown (where stated) in Luria-Bertani (LB) broth containing different salt concentrations (low salt, 0.09M NaCl; standard, 0.17M NaCl), in SPI-2 inducible conditions as described in [22], or in SPI-2 inducible conditions including either 0.5% glucose or 0.25% acetate [23]. Cultures were shaken at 37°C overnight and standardized to an OD600 of 1.0.

In all other experiments strains were grown in low salt LB broth. All S. Typhi cultures were supplemented with a mixture of aromatic amino acids (aro-mix; 4μg/ml phenylalanine, 4μg/ml tryptophan, 1μg/ml paraaminobenzoic acid and 1μg/ml dihydrobenzoic acid) and 4μg/ml tyrosine. Cultures were routinely shaken at 200rpm and incubated overnight at 37°C in a non-baffled flask. All mutant strains were grown with 30μg/ml kanamycin (Roche), 20μg/ml chloramphenicol (Sigma) or 30μg/ml ampicillin selection where appropriate.

Construction of the ΔyehUT mutant derivatives

The ΔyehUT mutant derivatives of S. Typhi BRD948 and S. Typhimurium ST4/74 were constructed using the λ red-recombinase system, described previously [24]. Bacteria were transformed with pSIM18 carrying the λ red-recombinase genes [25]. PCR amplification of the cat or aph genes using pKD3 or pKD4 (5ng/μl) respectively, with appropriate primers (Table S1 in File S1) that contain the priming sites GTGTAGGCTGGAGCTGCTTCG (forward) and CATATGAATATCCTCCTTAG (reverse), homologous to regions on the template plasmids. S. Typhi targeting primers were designed using the Ty2 genome sequence [26] and S. Typhimurium targeting primers were designed using the SL1344 genome sequence [27] as references (Table S1 in File S1). PCR conditions used were: 94°C for 2 min; 30 cycles of 94°C for 30s; 55°C for 30s; and 72°C for 2.5 min; final elongation 72°C for 7 min [24]. The PCR product (3-5ng) was transformed into S. Typhi pSIM18 and S. Typhimurium pSIM18, which had been grown in hygromycin broth to an OD600 of 0.4 and induced to express λ red recombinase with heating to 42°C for 15 minutes. Mutant clones that were able to grow on the appropriate antibiotic selective media were cultured overnight at 37°C.

Phage P22 lysates for S. Typhimurium were made on the transformants and used to transfer the antibiotic resistance gene into a fresh S. Typhimurium strain background. Plasmid pSIM18 was cured from S. Typhi and single colonies that grew on LB with appropriate antibiotic but failed to grow on hygromycin agar were selected as mutant clones. The FRT (FLP recognition target)-flanked antibiotic resistance cassette was then eliminated with pCP20, as previously described [28]. Unless stated otherwise mutations constructed as part of this work were designed to minimize polar effects unless otherwise stated.

In S. Typhimurium, mutations in yehUT were complemented by co-transducing wild type yehUT gene with a closely linked aph gene that conferred kanamycin resistance to transductants, into the chromosome of S. Typhimurium ΔyehUT::cat using phage P22. Bacterial colonies that grew on LB with kanamycin and failed to grow on LB with chloramphenicol were selected. PCR was then carried out to confirm that we had directly replaced the yehUT deletion with an intact yehUT copy (Table S2 in File S1).

In S. Typhi, the wild type yehUT coding sequence was PCR-amplified using primers (Table S2 in File S1). This DNA fragment was then digested by restriction enzymes XbaI and KpnI and ligated to the low copy plasmid pWKS30 [29]. The resulting vector was introduced into the mutant S. Typhi ΔyehUT::cat  by electroporation to produce the complement strain S. Typhi ΔyehUT::cat pWKS30:: yehUT::aph.

Construction of yehT::FLAG

A FLAG epitope tag peptide was added to the end of the yehT response regulator using a modification of the standard chromosomal gene disruption protocol [30]. A C-terminal FLAG translational fusion of yehT was constructed by PCR amplification of pSUB11 using primers gtaagccgtcgctatctgaaaagtttaaaagaggcgattggcctgGACTACAAAGACCATGACGG (forward) and ccttcggtcgtttctatggcaaaacgatattctaacagtcttttaATATGAATATCCTCCTTAG (reverse) (Table S1 in File S1). This PCR product was transformed into S. Typhi BRD948 and S. Typhimurium ST4/74 containing pSIM18.

Western blotting

Cultured bacterial cells were centrifuged and resuspended in 300μl of sterile PBS and immediately mixed with 300μL of Laemmli 4X lysis buffer (5% SDS; 10% 2-mercaptoethanol; 40% glycerol; 0.005% bromophenol blue; 250mM 16:24 Tris HCl pH 6.8). Suspensions were heated at 100°C for 5 minutes. Extracted proteins were separated by SDS-PAGE and visualized by Coomassie-blue staining (Sigma) to ensure equal gel loading of proteins. Bacterial proteins resolved by SDS-PAGE were transferred to a nitrocellulose membrane (Invitrogen) and detected with mouse anti-FLAG M2 monoclonal antibodies conjugated to horseradish peroxidase (HRP) (1:5000 (Sigma)), which were consequently bound to HRP-conjugated rabbit anti-mouse antibodies (1:5000 (Dako)). Detection was performed by chemiluminescence (Amersham ECL system, GE Healthcare)[30]. Proteins of the appropriate parental strain were used as a negative control (S. Typhi BRD948 or S. Typhimurium ST4/74) and S. Typhimurium SL1344 fliA FLAG was constructed as described for the yehT::FLAG and used as a positive control (27kDa).

DNA microarray analysis (Accession number GSE50825)

The mRNA transcriptional profiles of S. Typhi and S. Typhimurium and derivatives harboring ΔyehU, ΔyehT and ΔyehUT mutations were analyzed in at least three individual experiments. Overnight bacterial cultures grown in low salt LB shaking at 37°C were diluted to 1 in 100ml of LB broth and grown to an OD600 of 0.3 (mid-log phase). Total RNA of ≈ 1X109 cfu was extracted following treatment with 1mg/ml lysozyme for 5 minutes and purification using the RNeasy mini kit (Qiagen), following the manufacturer’s instructions.

RNA quantity and quality was analyzed using the 2100 Bioanalyser (Agilent) and 25ng/μl of RNA was used to generate cDNA. This was labeled with a single-colored dye probe (Cy3) and hybridized to the appropriate custom microarrays (Agilent). The arrays were scanned using the DNA high-resolution microarray scanner (Agilent). The raw data was normalized by the RMA method [31] and differentially expressed genes were identified using the “Limma” Package in R (Bioconductor) [32]. Those genes with at least two-fold difference in expression and an adjusted p-value of <0.05 (using the Benjamini-Hochberg method) were considered to be differentially expressed.

qRT-PCR

Genes that were significantly differentially expressed in the DNA microarray experiments were tested using qRT-PCR. Using RNA extracted and purified in the different DNA microarray experiments, cDNA was synthesized using QuantiTect Reverse Transcription kit (Qiagen) with random primers, according to the manufacturer’s instructions. PCR was conducted using 20ng/μl cDNA template in a 15μl reaction, with 0.5μM of each primer set (Table S3 and S4 in File S1) and Taq polymerase mix (Qiagen). PCR conditions used were: 95°C for 2 min; 40 cycles of 94°C for 15s; 60°C for 30s; 72°C for 30s; 95°C for 15s, 60°C for 1 min; and 95°C for 15s (Qiagen). The qRT-PCR was performed with a StepOne Plus machine (Applied Biosystems) using SYBR Green Dye (Qiagen). Fold change in gene expression was normalized to expression of the housekeeping gene recA using the delta-delta Ct method [33].

Invasion assay

Human laryngeal epithelial (HEp-2) cells were obtained from American Type Culture Collection (ATCC) 10801 University Boulevard Manassas, VA 20110, USA. The cells were maintained in DMEM-F12/L-Glut/FBS as described [34]. Bacteria for this invasion assay were first grown during the day by shaking in low salt LB at 220 rpm for 6 hours (at 37°C) followed by inoculating 0.5mls of this culture into 45mls fresh low salt LB in a 50ml falcon tube and left to grow statically overnight at 37°C [35]. Confluent monolayers of HEp-2 cells were inoculated at a dose of 106 cfu of bacteria. Infected monolayers were then incubated for 1 hour in a tissue culture incubator at 37°C, washed twice with Phosphate Buffer Saline (PBS), and then overlaid with tissue culture medium supplemented with 100μg/ml gentamicin. After 90 minutes, the cell culture was washed three times with PBS and lysed with 1% Triton X-100 in PBS to release intracellular bacteria. An aliquot of this suspension was used to determine the number of intracellular bacteria by plating serial dilutions onto LB agar plates. The bacterial counts of the control strains were compared with their respective ΔyehUT mutant derivatives.

Vi phage assay

S. Typhi BRD948 and its mutant derivative S. Typhi ΔyehUT were tested for sensitivity (plaque morphology) and susceptibility (bacterial counts) to Vi phage types II and VII [36]. The strains were grown in 3ml of LB left shaking overnight at 37°C. Molten 0.35% L-agar was cooled to 42°C, and 3ml aliquots were added to Falcon tubes containing 10μl of dilutions of Vi phage type II or VII (from 10-1 to 10- 7) and 150μl of the bacterial culture; the mixtures were poured immediately onto L-agar plates. The plates were left overnight at 37°C. The next day plaque morphology and count was compared.

Serum bactericidal assays with human sera

Killing of S. Typhi, S. Typhi ΔyehUT, and S. Typhi ΔyehUT::cat pWKS30::yehUT::aph and S. Typhimurium, S. Typhimurium ΔyehUT and S. Typhimurium ΔyehUT::cat yehUT::aph) with fresh, human serum were assessed as previously described [37]. Bacteria in log growth at a concentration of 1 x 107 cfu/ml were added at a 1:10 dilution to 100% human serum to give a final concentration of 1 x 106 cfu/ml and incubated at 37°C for 180 min on a rocker plate at 20rpm. Sera heat-inactivated at 56°C for 30 min were used as a control. Samples were taken at 45, 90 and 180-minute intervals. The concentration of Salmonella was determined by serial dilutions and plating on LB agar.

Mouse experiments

Acute infection mouse model.

Mixed competitive inhibition experiments was performed using groups of ten isofluorane-anaesthetized wild type C57BL/6 mice, which were orally inoculated, with 108 cfu of mixed culture of S. Typhimurium ΔphoN::aph and S. Typhimurium ΔyehUT::cat in 200μl of sterile PBS. The phoN gene is dispensible for the intestinal and systemic phases of murine salmonellosis [38]. Therefore it was deemed an appropriate chromosomal insertion site for the aph gene required to distinguish the control S. Typhimurium from the mutant derivatives [39,40]. All mice were weighed daily and monitored for signs of illness. For bacterial quantification tissue from the mesenteric lymph nodes (MLN), cecum, ileum, spleen and liver from the mice were collected on day 5-post infection and homogenized in 5ml of sterile PBS. Viable bacteria in the tissues were quantified by serial dilutions and plating onto LB agar containing the appropriate antibiotics to select for the Salmonella. Statistical tests were performed by the Wilcoxon signed-ranked test using Prism software (GraphPad Software Inc.) on the mixed competitive inhibition data. Differences between data sets where p < 0.05 were considered statistically significant.

Streptomycin-pretreated colitis mouse model.

A streptomycin experiment was performed using three groups of five mice. Mice were pre-treated with 50mg of streptomycin in 200μl of sterile water 24 hours prior to infection [41]. One group of five mice were naïve and the other two groups of five mice were anaesthetized using isofluorane and orally inoculated with 103 cfu of either S. Typhimurium ΔphoN::aph or S. Typhimurium ΔyehUT::cat, in 200μl of sterile PBS. All mice were weighed daily and monitored for signs of illness. All mice were culled on Day 3 of infection or mice exceeding 20% total weight loss were culled prior to Day 3 in accordance with UK Home Office guidelines. The ceca of the mice were collected, weighed and homogenized in 5ml of sterile PBS for bacterial quantification, qRT-PCR of inflammatory cytokines and pathological examination. Statistical analyses were performed on the data. Bacterial quantification in which viable bacteria was quantified by serial dilutions on LB agar containing the appropriate antibiotics to select for the Salmonella.

qRT-PCR of inflammatory cytokines: RNA was isolated from 3mm-long cecal sections using RNeasy Mini kit (Qiagen) according to manufacturer’s instruction. RNA integrity and quantity were then assessed using Agilent 2100 Bioanalyzer (Agilent Technologies). cDNA was then synthesized using QuantiTect Reverse Transcription kit (Qiagen) with random primers, according to the manufacturer’s instructions. All TaqMan qRT-PCR primers and probes were designed by Primer Express 3.0 (Applied Biosystems) to span exon-exon junction to avoid genomic DNA amplification. PCR was conducted using 5ng/μl cDNA template in a 25μl reaction, with 20μM of each cytokine primer set (Table S5 in File S1) and 10μM appropriate probe, according to manufacturer’s instructions (Thermo Scientific). The Gapdh gene was used as the endogenous control. The qRT-PCR was performed with a StepOne Plus machine (Applied Biosystems) using ABsolute Blue qRT-PCR Rox mix (Thermo Scientific). Relative gene expression was determined by normalization to Gapdh copy numbers [42].

Histopathology: To evaluate intestinal inflammatory disease histopathology, we fixed cecal segments in 4% paraformaldehyde and stained 5 μm-thick paraffin sections in hematoxylin and eosin according to standard protocols. Scoring of intestinal inflammation was performed in a blinded manner by a clinical consultant histopathologist with comparative pathology expertise, as follows: submucosal edema: mild-1, moderate-2, severe-3; submucosal cellular inflammation: mild-1, moderate-2, severe-3; mucosal cellular inflammation: mild-1, moderate-2, severe-3; crypt abscesses: absent-0, present (occasional/mild)-1, present (moderate/severe)-2; mucosal ulceration: absent-0, present (focal/mild)-1, present (moderate/severe)-2.

Statistical Analyses: Statistical tests were performed using the Mann-Whitney U test using U test (http://elegans.som.vcu.edu/~leon/stats/utest.cgi) on the data. Differences between data sets where p < 0.05 were considered statistically significant.

Phenotyping microarrays (BIOLOG)

Phenotype microarrays (PM) of metabolism of carbon sources (PM 1 to 2), nitrogen sources (PM 3), phosphorus and sulfur sources (PM 4), biosynthetic pathway substrates (PM 5), and peptide nitrogen sources (PM 6 to 8), osmotic/ionic response (PM 9), pH response (PM 10) and bacterial chemical sensitivity (PM 11 to 20) were performed according to manufacturer’s instructions. (Biolog Inc. Hayward, California, USA) [43]. S. Typhi BRD948 and S. Typhimurium ST4/74 were used as reference strains for comparison with their respective ΔyehUT mutants (S. Typhi ΔyehUT and S. Typhimurium ΔyehUT). PM micro titer plates were incubated at 37°C for 24 hours in the Omnilog (Biolog Inc.) and each well monitored for redox indictor change representing kinetic respiration. Tests were performed in triplicate and the kinetic data analyzed using Omnilog PM software (Biolog Inc.). Data was exported from the Biolog File Manager, and further analysis was conducted in R. Data was transformed in to “signal values” [44], and the Bioconductor package Limma [32] was used to test for differences in dye reduction. Benjamini-Hochberg corrected p-values were used to determine statistical significance, controlling for a false discovery rate of 5%.

Minimum inhibitory concentrations (MICs) of the ∆yehUT mutants of S. Typhi and S. Typhimurium were determined using Epsilometer test (E test) strips against antibiotics amoxicillin, tetracycline, ciprofloxacin, ceftriaxone, and meropenem (Oxoid, Hampshire, UK), trimethoprim-sulfamethoxazole and azithromycin (BioMérieux, SA, Marcy-L’Etoile, France). Semi-confluent growth was achieved using 0.5 McFarland organism bacterial suspensions [45] on Iso-Sensitest agar (Oxoid, Hampshire, UK) after 24 hours incubation aerobically at 37°C. Since the mutant strains were not clinical isolates parental strains were used as the controls to see if the deletion of yehUT had an effect on antibiotic susceptibility.

Results

Informatics analysis of the YehUT system

In S. Typhi Ty2 the yehU and the yehT genes are encoded on a 2,349 bp long fragment with a 4 bp overlap between the yehU and yehT open reading frames and are likely part of an operon. Neighboring genes include yehV, yehW, and yehX upstream of yehU, and yehS and yehR downstream from yehT. The genes yehX, yehW, yehU, yehT and yehS are located on the forward strand, whilst t0694, yehV, t0699 and yehR lie on the reverse strand (Figure 1) [26,46]. The function of these genes is not currently known, although our sequence comparison-using Interpro indicated that yehV and yehS encode a putative transcriptional regulator and a conserved hypothetical protein, respectively [16].

thumbnail
Figure 1. A The yehUT operon with surrounding genes.

The operon is 2349bp in length and located between 782210 to 784611 bp in S. Typhi Ty2 (Accession number AE014613) and between c2251460 to c253861 bp in S. Typhimurium SL1344 (Accession number FQ312003). The surrounding genes include yehV, t0694, yehW, yehX (upstream of yehU) and yehS, t0699 and yehR (downstream from yehT). B The domain organisation of the YehU and YehT proteins. YehU protein comprises of five transmembrane (TM) alpha helical segments predicted using TMHMM webserver [17]. The intracellular signalling component consists of a GAF domain, a DHp (dimerization/histidine-containing phosphotransfer) domain that is connected to an ATP (adenosine triphosphate)-dependent Kinase domain. YehT protein consists of a Receiver domain and a LyTR-homologous DNA binding domain [16]. The phosphorylation sites are indicated (H, Histidine; D, Aspartate). The SNP positions identified in yehU and yehT genes are indicated below the proteins by grey boxes [10].

https://doi.org/10.1371/journal.pone.0084567.g001

The domain architecture of YehU and YehT was predicted from a consensus definition from Interpro [16]. These results predicted four domains in YehU (sensor, GAF, histidine phosphotransfer (DHp) and kinase domains) and two in YehT, (receiver and cell envelope-related transcriptional attenuator (LytR) domains) (Figure 1). The sensor domain is predicted to contain at least 5 transmembrane helices [17]. GAF domains are so-called because they are found in cGMP-specific phosphodiesterases, adenylyl cyclases and transcriptional activators, including formate hydrogen lyase system activators (FhlA), and although their precise function is not clear they may be involved in ligand binding and protein-protein interaction [47]. The LytTR domain named after the Bacillus subtillus LytT and Staphylococcus aureus LytR response regulators contains a specific DNA-binding motif and is commonly found in a number of bacterial transcriptional regulators [48]. The YehU/YehT system was compared to EnvZ/OmpR and revealed that YehU does not have a histidine residue at position 243 as in the sensor kinase EnvZ [49].

YehT expression in different media

In order to study the function of the YehUT system we initially determined the optimal conditions in which the YehT protein of S. Typhi and S. Typhimurium was expressed. To this end a S. Typhi and S. Typhimurium derivative was constructed that directed the expression of a YehT fusion protein fused at the C-terminal with the epitope-tag FLAG. Whole protein preparations from these derivatives cultured in five alternative media indicated that YehT was expressed in all conditions. In S. Typhi, YehT was expressed at relatively higher level in low salt LB (0.09M NaCl) than standard LB (0.17M NaCl). In a further experiment, expression was also slightly higher in a minimal medium designed to induce SPI-2, compared to the same medium additionally containing either glucose or acetate (Figure 2). However, in S. Typhimurium the overall level of expression of YehT was relatively low in all five culture media (Figure 3). Therefore, low salt LB was selected as the best growth media for determination of yehUT dependent transcription analysis and elucidation of the phenotype of ΔyehUT for both S. Typhi and S. Typhimurium.

thumbnail
Figure 2. SDS-PAGE and western blot analysis of epitope-tagged YehT protein from S.

Typhi BRD948.

Proteins from whole cell bacterial lysates were transferred after electrophoretic separation in a 12% SDS-PAGE gel (Invitrogen) onto a nitrocelluose membrane (Invitrogen) and probed with anti-FLAG M2 monoclonal antibodies (Sigma). Lanes: (M) protein molecular weight markers (SeeBlue Plus2 Pre-stained standard; Invitrogen); (-) proteins extracted from S. Typhi BRD948 (negative control); (+) proteins extracted from S. Typhimurium SL1344 ΔfliA (positive control, 27.4kDa); FLAG proteins extracted from S. Typhi ΔyehT-tagged (27.4kDa). Bacteria was grown in low salt LB; normal salt LB; SPI-2 inducing; SPI-2 + 0.5% glucose; SPI-2 + 0.25% acetate overnight, shaking at 37°C.

https://doi.org/10.1371/journal.pone.0084567.g002

thumbnail
Figure 3. SDS-PAGE and western blot analysis of epitope-tagged YehT protein from S.

Typhimurium ST4/74.

Proteins from whole cell bacterial lysates were transferred after electrophoretic separation in a 12% SDS-PAGE gel (Invitrogen) onto a nitrocelluose membrane (Invitrogen) and probed with anti-FLAG M2 monoclonal antibodies (Sigma). Lanes: (M) protein molecular weight markers (SeeBlue Plus2 Pre-stained standard; Invitrogen); (-) proteins extracted from S. Typhimurium ST4/74 (negative control); (+) proteins extracted from S. Typhimurium SL1344 ΔfliA (positive control; 27.4kDa); FLAG proteins extracted from S. Typhimurium ΔyehT-tagged (27.4kDa). Bacteria was grown in low salt LB; normal salt LB; SPI-2 inducing; SPI-2 + 0.5% glucose; SPI-2 + 0.25% acetate overnight, shaking at 37°C.

https://doi.org/10.1371/journal.pone.0084567.g003

Identification of yehUT regulated genes

In order to elucidate the role of yehUT on global gene expression, we performed transcriptome profiling based on microarray analysis of mRNA purified from S. Typhi and otherwise isogenic mutant derivatives harboring non-polar deletions of yehUT or either one of these two genes. S. Typhi and all mutant derivatives, including ΔyehUT S. Typhi grew at comparable rates (data not shown). Analysis of differentially expressed genes relative to the average expression level of each gene across all arrays was performed and genes that showed a statistically significant change in expression in mutant compared to S. Typhi control strain were identified (Accession number GSE50825) [32]. The differentially expressed genes were grouped into functional classes based on genome annotation [50].. Transcriptome analysis of the S. Typhi transcriptome compared to the ΔyehU, ΔyehT and ΔyehUT mutant derivatives provided evidence of relative down regulation in each of the mutants of three genes: cstA1 (t4582), encoding a carbon starvation protein, and t4581 and t4580 annotated as conserved hypotheticals (Table 1).

GenesGene IDPutative identification of NCBI databaseFunctional categoryLog2 fold change (FC)Adjusted p-value
yehU mutant
cstA1t4582carbon starvation proteinI -6.517056711 4.24E-07
-t4581hypothetical protein t4581III -3.984595019 3.42E-04
-t4580GTP-binding protein YjiAIII -2.282197911 4.17E-02
yehT mutant
cstA1t4582carbon starvation proteinI-6.36E+005.44E-07
-t4581hypothetical protein t4581III-3.91E+004.12E-04
-t4580GTP-binding protein YjiAIII-2.41E+003.50E-02
yehUT mutant
cstA1t4582carbon starvation proteinI-6.47E+004.56E-07
-t4581hypothetical protein t4581III-3.68E+004.95E-04
-t4221AraC family transcriptional regulatorV-1.94E+001.45E-02
-t4220GerE family regulatory proteinV-1.55E+001.62E-02
spaMt2795virulence-associated secretory proteinI-1.52E+001.62E-02
-t4580GTP-binding protein YjiAIII-2.32E+002.04E-02
spaNt2794antigen presentation protein SpaNI-1.57E+002.23E-02
spaIt2796ATP synthase SpaII-1.46E+002.23E-02
pipBt1830hypothetical protein t1830I-1.54E+002.61E-02
-t1038hypothetical protein t1038II 1.03E+004.21E-02
yiiDt3592AcetyltransferaseIV-8.89E-014.21E-02
ppct3505phosphoenolpyruvate carboxylaseVII-1.25E+004.21E-02
Ntht1321endonuclease IIIVI 1.26E+004.21E-02
-t3408hypothetical protein t3408VIII-9.93E-014.60E-02
sopEt4303invasion-associated secreted proteinVIII-1.92E+004.96E-02

Table 1. DNA microarray analysis of S. Typhi ΔyehUT compared to S. Typhi BRD948, grown in low salt LB at mid-log phase.

Differential expression profiles were represented by a log2 fold change (FC) value – a positive value indicates the gene is up regulated in the mutant strain compared to S. Typhi; a negative value indicates the gene is down regulated in the mutant strain compared to . Key genes identified based on an adjusted p-value of <0.05 using the Benjamini-Hochberg method [32]. Gene annotation was performed using the S. Typhi Ty2 database at NCBI (http://www.ncbi.nlm.nih.gov/; Accession number AE014613). Functional categories as annotated in the S. Typhi CT18 genome (Accession number AL513382) Code: I – pathogenicity/adaptation; II – hypothetical (unknown function); III – conserved hypothetical; IV – central/intermediary metabolism; V – regulators; cyan VI – degradation of macromolecules; VII energy metabolism; VIII – phage-related functions/IS elements.
CSV
Download CSV

The cstA1 gene was the most differentially expressed in all mutant derivatives compared to S. Typhi. This gene is located in the same chromosomal region as t4581 and t4580 on the reverse strand of the S. Typhi Ty2 genome: cstA1 (t4582) is situated at c4734842 bp to c4736992 bp, with t4581 95 bp and t4580 309 bp downstream, respectively [18]. Previous RNA-sequencing data has shown that these genes are transcribed in vitro at 37°C during mid-log phase [51]. The cstA1 gene was identified as a putative carbon starvation protein using the NCBI database [52,53]. Furthermore, the gene is predicted to encode a membrane protein involved in peptide utilization to avoid carbon starvation as the bacterium enters stationary phase [54]. This protein appears to be conserved in the Enterobacteriaceae, including Salmonella species [54]. cstA has been described as a cAMP-CRP (cyclic adenosine monophosphate-catabolite regulation protein) dependent gene in E. coli when the concentration of cAMP rises during carbon starvation activating the gene [55].

Both NCBI and Pfam databases identified t4581 as encoding a hypothetical protein of unknown function, although structural modeling suggested a domain that might bind nucleic acids [52-54]. Gene t4580 is predicted to encode a putative GTP-binding protein (YjiA), using NCBI [52,53]. In E. coli the crystal structure supports a GTP-dependent function, but the biological role of the protein remains unclear [56].

Transcriptome analysis of the S. Typhi ΔyehUT mutant displayed not only dysregulation of cstA1, t4580 and t4581, but also an additional 12 genes: ten genes were down regulated and two up regulated (Table 1). These genes were not differentially expressed in either of the single mutants. There was relative down regulation of a number of Salmonella Pathogenicity Island (SPI) associated genes, including spaM, spaN, and spaI located on SPI-1, pipB situated in SPI-5, and the SPI-7 encoded gene sopE [57]. Other down regulated genes included t4221, a member of the AraC family transcriptional regulator family and t4220, a GerE family regulatory protein. Metabolic genes relatively down regulated in the S. Typhi ΔyehUT mutant included ppc, which encodes phosphoenolpyruvate carboxylase, an enzyme involved in the oxidation of carbohydrates via the tricarboxylic acid cycle [58] and yiiD, a galactoside O-acetyltransferase, which in E. coli may assist cellular detoxification by acetylating non-metabolizable pyranosides and thereby preventing their reentry into the cell [59]. The two genes that were up regulated in the double mutant were the nth gene, which encodes endonuclease III involved in the DNA repair system [60,61] and t1038, which encodes an unknown hypothetical protein.

The differential expression of several genes, including cstA1, t4581, t4580, spaM, spaN, spaI and sopE, were validated using qRT-PCR. The overall pattern of up and down regulation of genes was identical to the microarray results (Table S6 in File S1; Figure 4a). Complementation of the ΔyehUT mutant with plasmid-encoded yehUT restored expression of the genes, although many of the genes were then relatively over-expressed, which is most likely a result of the high copy number of plasmids containing yehUT (Table S6 in File S1; Figure 4b).

thumbnail
Figure 4. qRT-PCR analyses of differentially expressed genes of the S.

Typhi ΔyehUT mutant.

A The relative expression levels of the 15 genes found to be differentially expressed on microarray analysis of the S. Typhi ΔyehUT mutant when compared to S. Typhi in low salt LB, at mid-log phase, at 37°C (Table S6 in File S1). The 15 genes examined are listed on the y-axis. Grey boxes < 1.0 indicates down regulated genes and grey boxes >1.0 indicates up regulated genes relative to S. Typhi. B qRT-PCR analysis showing relative expression levels of genes after complementation of the ΔyehUT mutant compared to S. Typhi (Table S6 in File S1).

https://doi.org/10.1371/journal.pone.0084567.g004

Phenotypic analysis of the yehUT deletion mutant derivatives of S. Typhi

S. Typhi BRD948 and its ΔyehUT mutant derivative were phenotypically analyzed using serum bactericidal assays (Graph B in Figure S1), tissue invasion assays with Hep2 cells (Graph A in Figure S2), and a Vi phage sensitivity assay (Figure S3), but no significant differences were observed. There was no metabolic phenotype identified for S. Typhi ΔyehUT using phenotypic Biolog microarrays, which monitors a range of different growth conditions, including various substrates, ionic concentrations (pHs) and osmolarities. Furthermore, no difference in MIC was observed between S. Typhi and the ΔyehUT mutant derivative when tested against a range of antibiotics commonly used to treat Salmonella infections, including amoxicillin, ceftriaxone, ciprofloxacin, trimethoprim-sulfamethaxole, meropenem and azithromycin.

Properties of a yehUT deletion mutant derivative of S. Typhimurium

The two-component regulatory system yehUT is also present in S. Typhimurium which allowed us to use this serovar for a comparison against S. Typhi and as a surrogate in vivo model of typhoid fever. Informatics analysis of the S. Typhimurium SL1344 genome identified one non-synonymous SNP in yehT and four non-synonymous SNPs in yehU compared to S. Typhi CT18 (Table S7 in File S1) [18]. The consensus encoded polypeptides are almost identical in both serovars with only four amino acid differences in YehU and two amino acid difference in YehT identified between S. Typhi Ty2 and S. Typhimurium SL1344, with no difference observed between predicted protein structures [20,21,54].

Transcriptome analysis of mRNA prepared from S. Typhimurium and the yehUT mutant derivatives, provided evidence for the comparative down regulation of the same four genes identified in similar experiments with S. Typhi: cstA1 (SL1344_4463), cstA2 (SL1344_0588) and hypothetical proteins SL1344_4462 and SL1344_SPAB_05703 (Accession number GSE50825) (Table 2). Three out of the four genes (cstA1, SL1344_4462 and SL1344_SPAB_05703) were confirmed by qRT-PCR to be relatively down regulated in the ΔyehUT mutant (Table S6 in File S1; Figure 5a). Expression of these genes was restored by complementation of the ΔyehUT mutant (Table S6 in File S1; Figure 5b). On further analysis these genes are found in the same region in the genome with the cstA1 gene located at c4808148bp to c4810298 bp on the reverse strand, SL1344_4462 situated 95bp downstream of cstA1 on the same strand and SL1344_SPAB_05703 overlapping upstream of cstA1 on the forward strand (4810246 bp to 4810350 bp) [18]. Gene SL1344_4462, like t4581 of S. Typhi, is predicted to bind nucleic acids. However, the function of SL1344_SPAB-05703 is unknown [54]. The second cstA gene (cstA2) was not differentially expressed on qRT-PCR.

GenesGene IDPutative identification of NCBI databaseFunctional categoryLog2 FCAdjusted p value
yehU mutant
cstA1SL1344_4463carbon starvation proteinI-7.36E+001.06E-09
--hypothetical protein SPAB_05703--3.82E+001.24E-06
-SL1344_4462hypothetical protein STY4889III-3.06E+003.45E-06
cstA2SL1344_0588hypothetical protein SPAB_02963 (carbon starvation protein)II-2.89E+009.25E-03
yehT mutant
cstA1SL1344_4463carbon starvation proteinI-7.33E+005.49E-10
--hypothetical protein SPAB_05703--3.79E+001.32E-06
-SL1344_4462hypothetical protein STY4889III-2.94E+005.16E-06
cstA2SL1344_0588hypothetical protein SPAB_02963 (carbon starvation protein)II-3.58E+001.25E-03
yehUT mutant
cstA1SL1344_4463carbon starvation proteinI-7.66E+004.23E-10
--hypothetical protein SPAB_05703--3.94E+008.86E-07
-SL1344_4462hypothetical protein STY4889III-2.68E+001.33E-05
cstA2SL1344_0588hypothetical protein SPAB_02963 (carbon starvation protein)II-3.47E+001.70E-03

Table 2. DNA microarray analysis of S. Typhimurium ΔyehUT mutants compared to S. Typhimurium, grown in low salt LB at mid-log phase.

Differential expression profiles were represented by a log2 fold change (FC) value – a positive value indicates the gene is up regulated in the mutant strain compared to S. Typhimurium; a negative value indicates the gene is down regulated in the mutant strain compared to S. Typhimurium. Key genes identified based on an adjusted p-value of <0.05 using the Benjamini-Hochberg method [32]. Gene annotation was performed using the S. Typhimurium SL1344 genome (Accession number FQ312003) [46]. Functional categories: I – pathogenicity/adaptation; II – hypothetical (unknown function); III – conserved hypothetical; IV – central/intermediary metabolism; V – regulators; cyan VI – degradation of macromolecules; VII energy metabolism; VIII – phage-related functions/IS elements.
CSV
Download CSV
thumbnail
Figure 5. qRT-PCR analyses of differentially expressed genes of the S.

Typhimurium ΔyehUT mutant.

A The relative expression levels of the 4 genes found to be differentially expressed on microarray analysis of the S. Typhimurium ΔyehUT mutant when compared to S. Typhimurium. in low salt LB, at mid-log phase, at 37°C (Table S6 in File S1). The 4 genes examined are listed on the y-axis. Grey boxes < 1.0 indicates down regulated genes and grey boxes >1.0 indicates up regulated genes relative to S. Typhimurium. B qRT-PCR analysis showing relative expression levels of genes after complementation of the ΔyehUT mutant compared to S. Typhimurium.(Table S6 in File S1).

https://doi.org/10.1371/journal.pone.0084567.g005

For S. Typhimurium and its ∆yehUT mutant derivative a range of virulence experiments were performed including serum bactericidal assays (Graph A in Figure S1), tissue invasion assays (Graph B in Figure S2), acute infection mouse model (Figure S4) and streptomycin-treated colitis mouse model (Figure S5-S7). No difference was observed between these isolates. There was also no metabolic phenotype identified for S. Typhimurium ΔyehUT using phenotypic Biolog microarrays or E-tests against antibiotics amoxicillin, ceftriaxone, ciprofloxacin, trimethoprim-sulfamethaxole, meropenem, azithromycin and tetracycline.

Discussion

S. Typhi is a Gram-negative organism that causes the disease typhoid fever and is spread fecal-orally by ingestion of contaminated food or water [8]. Unlike most S. enterica serovars, S. Typhi is a human restricted pathogen that entered the human population once relatively recently. Thus, all S. Typhi can be mapped phylogenetically back to a common ancestor and the genomes of collections of S. Typhi exhibit limited genetic variation [10]. That the yehUT operon of S. Typhi was found to contain an unusually high number of SNPs compared to the rest of the genome was therefore of potential significance in the evolution of this pathogen [10]. In addition, large scale transposon mutagenesis (TraDIS) data obtained by investigation of S. Typhimurium mutant survival during infection of mice, chickens, pigs and cattle showed that a single insertion in the yehT gene had a significant attenuation in calves (www-tradis.vet.cam.ac.uk). Consequently we combined transcriptome analysis and phenotypic assays to gain a better understanding of this system in Salmonella.

The transcriptome analysis for both S. Typhi and S. Typhimurium containing ΔyehU, ΔyehT or ΔyehUT revealed relative down regulation of cstA1 associated with the response to carbon starvation along with two neighboring hypothetical genes: t4580 and t4581 of S. Typhi; SL1344_4462, and SL1344_SPAB_05703 of S. Typhimurium. These three genes are situated within the same region of the genome of both serovars. The cstA gene was previously shown in E. coli to be positively regulated by the cyclic AMP (cAMP) and cAMP receptor protein (CRP) complex and to be involved in peptide utilization during carbon starvation [55,62,63]. In E. coli, expression was increased upon exhaustion of succinate, glycerol, or glucose from the medium, or upon entering stationary phase in LB [62]. CstA has been implicated as a peptide transporter [63], supported by sequence analysis that revealed the CstA protein consists of 701 amino acids and a hydrophobicity profile suggestive of an integral membrane protein [64]. A CstA homologue YjiY (>96% identity) was also up regulated when yehT was over expressed in E. coli [3]. Furthermore, YjiY, like CstA, may take part in amino acid/peptide utilization [3]. The remaining 31 genes differentially expressed in the E. coli study did not match the genes differentially expressed in Salmonella. However, Kraxenberger et al. [3] utilized over expression of the yehT gene compared to our mutant derivatives, which may account for at least some of the difference in gene expression profiles.

S. Typhi ΔyehUT exhibited differential expression of a further 12 genes compared to the ∆yehU and ∆yehT mutant derivatives, including genes involved in metabolism (yiiD, ppc) pathogenicity (spaM, spaN, spaI, pipB) and regulation (AraC, GerE). This suggested that yehUT might modulate metabolism or virulence functions of S. Typhi; hence we went on to test the mutant in various biochemical and virulence assays. The difference in gene expression observed between the derivatives harboring individual and double gene deletions in S. Typhi might be indicative of cross-regulation between yehUT and another two-component regulatory system compensating for the lone loss of the sensor kinase or response regulator in the yehUT system [65,66].

An independent study reported relative dysregulation of 26 genes in an S. Typhi GIFU10007ΔyehT mutant derivative under hypotonic conditions [67]. This dysregulation is somewhat more extensive than the three genes (cstA1, t4580, t4581) we identified using a ΔyehT mutant derivative of S. Typhi BRD948. The number of genes differentially expressed (26 genes) is more compatible with the analysis obtained from our ΔyehUT mutant (15 genes), with four genes (spaN, spaM, spaI, pipB) apparently dysregulated in both studies. It is noteworthy that the cstA1 gene was not differentially expressed to a statistically significant level in their study and yet was the top dysregulated gene here in both S. Typhi and S. Typhimurium yehUT mutant derivatives under isotonic conditions. These differences in transcriptome profiling of yehUT may be due to differences in the experimental conditions or to the use of different parental strains.

Genetic regulation of the yehUT operon is not well characterized. Differential regulation of yehU or yehT was not seen in a previous study in which we identified genes by microarray and RNA-seq of S. Typhi BRD948 that exhibited OmpR-dependent transcription, during mid log phase, in LB media [68]. However, another study showed that OmpR positively regulated expression of yehUT in S. Typhi GIFU10007 at low osmolarity [67]. One explanation for this discrepancy is that OmpR only induces yehUT expression when the osmolarity is lowered.

It has been proposed that YehU activates YehT by phosphorylation of a conserved histidine residue at position 382 [3]. In E. coli mutations in the putative histidine residue of YehU involved in phosphotransfer (position 382) and YehT (position 54) impacted expression of yjiY, a component of the yehUT regulon, suggesting an important role for phosphorylation at these sites [3]. A previous study has shown that autophosphorylation of YehU and phosphotransfer to YehT were barely detectable under all conditions tested [4]. However, YehU was shown to have no identifiable F box, which is a component of the histidine protein kinase domain involved in ATP binding, and probably also catalysis and phosphotransfer. This property may explain this reduction in phosphorylation [69]. In silico analysis predicted a histidine phosphotransfer (DHp) domain component of YehU, but the conserved histidine residue at 382 was not seen in second sensor kinase EnvZ on alignment comparison suggesting that these regulators have distinct mechanisms of signal transduction.

There are two copies of cstA gene homologues with a comparable identity of 61.9% in the genomes of both S. Typhi and S. Typhimurium serovars: cstA1 (S. Typhi t4582; S. Typhimurium SL1344_4463), which was differentially expressed in our microarray analysis and cstA2 (S. Typhi t2268; S. Typhimurium SL1344_0588), which was confirmed not to be dysregulated [20,21]. In a previous study we demonstrated that OmpR negatively regulates cstA2 in both S. Typhi and S. Typhimurium, using DNA microarray analysis, but exerts no effect on cstA1 [68]. A clearer understanding of the regulatory networks of both cstA1 and cstA2 may provide clues to how Salmonella is continually fine tuning its adaption to its host and environment.

Other than within the transcriptome profile, we were unable to identify a phenotype for S. Typhi or S. Typhimurium harboring mutations in yehUT. Despite the transcriptome analysis of S. Typhi ΔyehUT revealing dysregulation of a number of SPI genes yehUT mutant derivatives were able to invade cultured epithelial cells at rates comparable to control and showed no difference the mouse infection models compared to the parental strain. This is supported by studies in E. coli in which a phenotype for ΔyehUT mutant was also not detected [3,5].

The yehUT operon of S. Typhi may be undergoing either adaptive evolution due to host or environmental stresses or possibly a form of relaxed evolution as evidenced by the accumulation of a high number of non-synonymous SNPs. Further investigation into the biological complexity of these individual SNPs within S. Typhi needs to be undertaken to answer these questions more fully.

Supporting Information

Figure S1.

Resistance to killing by human serum of (A) Salmonella Typhimurium ST4/74, S. Typhimurium ST4/74 ΔyehUT and S. Typhimurium ∆yehUT::cat :: yehUT::aph, and (B) S. Typhi BRD 948, S. Typhi ΔyehUT and S. Typhi ∆yehUT ::cat pWKS30::yehUT::aph.

Deletion of yehUT had no detectable impact on the resistance to antibody-mediated, complement dependent killing of either S. Typhimurium (A) or S. Typhi (B) (p>0.05 for all time points). Complementation of the yehUT locus for both S. Typhimurium and S. Typhi mutant derivatives also had no detectable effect on resistance to serum killing. Data for each line represent the mean of the results from 10 healthy adult donors done in triplicate. The initial concentration of bacteria in the assay is approximately 1x106 cfu/ml. Negative values show a decrease in the number of viable bacteria over time. Error bars represent SEM.

https://doi.org/10.1371/journal.pone.0084567.s001

(EPS)

Figure S2.

Comparison of the ability of (A) S. Typhi BRD 948 and S. Typhi ΔyehUT, and (B) S. Typhimurium ST4/74 and S. Typhimurium ST4/74 ΔyehUT to invade HEp-2 cells.

For each isloate three experiments were conducted with bacteria grown by shaking in low salt LB for 6 hours at 37°C followed by inoculating 0.5mls of this culture into 45mls fresh low salt LB in a 50ml falcon tube. These samples were left to grow statically overnight at 37°C. Each column represents the mean and SEM of numbers of viable bacteria recovered from three separate wells. In (A) the data was normalized to S. Typhi BRD948 and the invasiveness of S. Typhi ΔyehUT was not obviously affected (p=0.38). In (B) the data was normalized to S. Typhimurium ST4/74 and the invasiveness of S. Typhimurium ΔyehUT was also not obviously affected (p=0.33).

https://doi.org/10.1371/journal.pone.0084567.s002

(EPS)

Figure S3.

Vi phage assays of S. Typhi BRD948 and S. Typhi ΔyehUT.

Plaque morphology and plaque counts (pfu/ml) were assessed after overnight Vi phage types II and VII infections of both S. Typhi BRD948 and S. Typhi BRD948 yehUT. There was no significant difference between S. Typhi and S. Typhi yehUT in terms of plaque morphology or counts for either Type II (p=0.41) or Type VII (p=0.66) phage infections.

https://doi.org/10.1371/journal.pone.0084567.s003

(EPS)

Figure S4.

Mixed competitive inhibition mouse experiment of S. Typhimurium ST4/74 and S. Typhimurium ∆yehUT.

The competitive index (CI) ratio of output (∆yehUT mutant/S. Typhimurium ST4/74) / input (∆yehUT / S. Typhimurium ST4/74) was calculated for bacterial colony-forming units (CFU) in tissue from mesenteric lymph nodes (MLN), cecum, ileum, spleen and liver of five C57BL/6 mice orally inoculated with 108 CFU of S. Typhimurium ST4/74 and the ∆yehUT derivative of this parental isolate. This experiment was performed twice. Mean (central bars) and 95% confidence intervals (error bars) are shown. Results showed that there were no significant differences in bacterial counts between S. Typhimurium ST4/74 and S. Typhimurium ∆yehUT in the MLN (p= 0.5), cecum (p=0.91), ileum (p=0.50), spleen (p=0.04) and liver (p= 0.004).

https://doi.org/10.1371/journal.pone.0084567.s004

(EPS)

Figure S5.

Cecal bacterial counts of S. Typhimurium ST4/74, S. Typhimurium ∆yehUT and S. Typhimurium ∆yehUT::cat :: yehUT::aph, in the streptomycin-pretreated colitis mouse experiment.

CFUs in tissue from cecum of five C57BL/6 mice pretreated with 50mg of streptomycin and then 24 hours later orally inoculated with 103 CFU of either (a) S. Typhimurium ST4/74, (b) S. Typhimurium ∆yehUT or (c) S. Typhimurium ∆yehUT::cat:: yehUT::aph. This experiment was performed three times. Mean (central bars) and SEM (error bars) are shown. The results showed that there were no significant differences between S. Typhimurium ST4/74 and the ∆yehUT derivative (p=0.16) and between ∆yehUT and ∆yehUT::cat:: yehUT::aph (p=0.62).

https://doi.org/10.1371/journal.pone.0084567.s005

(EPS)

Figure S6.

Histopathological scoring of cecal segments of S. Typhimurium ST4/74, S. Typhimurium ∆yehUT and S. Typhimurium ∆yehUT::cat :: yehUT::aph in the streptomycin-pretreated colitis mouse experiment.

Histopathological scoring of hematoxylin and eosin stained mouse cecal segments after five C57BL/6 mice were pretreated with 50mg of streptomycin and then 24 hours later orally inoculated with 103 CFU of either S. Typhimurium ST4/74, S. Typhimurium ∆yehUT or S. Typhimurium ∆yehUT::cat:: yehUT::aph. This experiment was performed three times. Scoring of intestinal inflammation was conducted by a Consultant Histopathologist and was as follows: submucosal edema: mild-1, moderate-2, severe-3; submucosal inflammation: mild-1, moderate-2, severe-3; mucosal inflammation: mild-1, moderate-2, severe-3; crypt abscesses: absent-0, present (occasional/mild)-1, present (moderate/severe)-2; mucosal ulceration: absent-0, present (focal/mild)-1, present (moderate/severe)-2. There were no significant differences in total pathological scores between the three groups.

https://doi.org/10.1371/journal.pone.0084567.s006

(EPS)

Figure S7.

qRT-PCR of inflammatory cytokines from cecal segments of S.Typhimurium ST4/74, S. Typhimurium ∆yehUT and S. Typhimurium ∆yehUT::cat :: yehUT::aph in the streptomycin-pretreated colitis mouse experiment.

qRT-PCR of inflammatory cytokines from mouse cecal segments after four groups of five C57BL/6 mice were pretreated with 50mg of streptomycin and then 24 hours later either not infected with bacteria (a=naive) or orally inoculated with 103 CFU of (b) S. Typhimurium ST4/74, (c) S. Typhimurium ∆yehUT or (d) S. Typhimurium ∆yehUT::cat:: yehUT::aph. This experiment was performed twice. Cytokine levels of IL-1, IL-6, KC, Mip-2, TNF-α, IFN-γ, iNOS, and Lys6-G were measured using qRT-PCR and the relative gene expression determined by normalization to Gapdh. The mean (central bars) and SEM (error bars) are shown. The results showed that there were no significant differences between (b) S. Typhimurium ST4/74 and (c) ∆yehUT for IL-1 (p=0.74), IL-6 (p=0.5), KC (p=0.67), Mip-2 (p=0.35), TNF-α (p=0.58), IFN-g (0.58), iNOS (p=0.31) and Lys6-G (p=0.89).

https://doi.org/10.1371/journal.pone.0084567.s007

(EPS)

File S1.

Supporting Information Tables: Supplementary data for Characterization of the yehUT two-component regulatory system of Salmonella enterica serovar Typhi and Typhimurium. Table S1. Primers used to construct the yehUT mutants of S. Typhi BRD948 and S. Typhimurium ST4/74. Primers used in this study. The nucleotides denoted in small letters are homologous to regions adjacent to the target gene and the nucleotides in capital letters are homologous to the template plasmids, pKD3 or pKD4, carrying antibiotic resistance genes that are flanked by FRT (FLP recognition target) sites; Table S2. Primer used to construct the complement mutants of S. Typhi BRD948 ΔyehUT and S. Typhimurium ST4/74 ΔyehUT. Primers used in this study. The nucleotides denoted in small letters are homologous to regions adjacent to the target gene and the nucleotides in capital letters are homologous to the template plasmids carrying antibiotic resistance genes that are flanked by FRT (FLP recognition target) sites; Table S3. Primers used in the qRT-PCR gene expression experiment of S. Typhi BRD948 ΔyehUT mutant; Table S4. Primers used in the qRT-PCR gene expression experiment of S. Typhimurium ΔyehUT mutant; Table S5. Primers used in the mouse cecal qRT-PCR cytokine experiment; Table S6. qRT-PCR analyses of differentially expressed genes of the S. Typhi ΔyehUT mutant and S. Typhimurium ΔyehUT mutant; Table S7. SNPs identified by informatics analysis of the yehUT genes of the S. Typhimurium SL1344 genome (Accession number: FQ312003). Coordinates correspond to S. Typhi CT18 finished genome sequence (Accession number: AL513382).

https://doi.org/10.1371/journal.pone.0084567.s008

(DOCX)

Author Contributions

Conceived and designed the experiments: GD RAK DJP CAM KS LJK KEH. Performed the experiments: VKW TMW PJH SJK LK LFM LE DJP. Analyzed the data: VKW RB CJM LB AJP MJA. Contributed reagents/materials/analysis tools: GD KS CJM RB CAM PJH LB. Wrote the manuscript: VKW DJP RAK GD. Designed the software used in analysis: LB.

References

  1. 1. Gao R, Mack TR, Stock AM (2007) Bacterial response regulators: versatile regulatory strategies from common domains. Trends Biochem Sci 32: 225-234. doi:https://doi.org/10.1016/j.tibs.2007.03.002. PubMed: 17433693.
  2. 2. Pickard D, Li J, Roberts M, Maskell D, Hone D et al. (1994) Characterization of defined ompR mutants of Salmonella typhi: ompR is involved in the regulation of Vi polysaccharide expression. Infect Immun 62: 3984-3993. PubMed: 8063417.
  3. 3. Kraxenberger T, Fried L, Behr S, Jung K (2012) First insights into the unexplored two-component system YehU/YehT in Escherichia coli. J Bacteriol 194: 4272-4284. doi:https://doi.org/10.1128/JB.00409-12. PubMed: 22685278.
  4. 4. Yamamoto K, Hirao K, Oshima T, Aiba H, Utsumi R et al. (2005) Functional characterization in vitro of all two-component signal transduction systems from Escherichia coli. J Biol Chem 280: 1448-1456. PubMed: 15522865.
  5. 5. Zhou L, Lei XH, Bochner BR, Wanner BL (2003) Phenotype microarray analysis of Escherichia coli K-12 mutants with deletions of all two-component systems. J Bacteriol 185: 4956-4972. doi:https://doi.org/10.1128/JB.185.16.4956-4972.2003. PubMed: 12897016.
  6. 6. Hirakawa H, Nishino K, Hirata T, Yamaguchi A (2003) Comprehensive studies of drug resistance mediated by overexpression of response regulators of two-component signal transduction systems in Escherichia coli. J Bacteriol 185: 1851-1856. doi:https://doi.org/10.1128/JB.185.6.1851-1856.2003. PubMed: 12618449.
  7. 7. Hirakawa H, Nishino K, Yamada J, Hirata T, Yamaguchi A (2003) Beta-lactam resistance modulated by the overexpression of response regulators of two-component signal transduction systems in Escherichia coli. J Antimicrob Chemother 52: 576-582. doi:https://doi.org/10.1093/jac/dkg406. PubMed: 12951338.
  8. 8. House D, Bishop A, Parry C, Dougan G, Wain J (2001) Typhoid fever: pathogenesis and disease. Curr Opin Infect Dis 14: 573-578. doi:https://doi.org/10.1097/00001432-200110000-00011. PubMed: 11964878.
  9. 9. Roumagnac P, Weill FX, Dolecek C, Baker S, Brisse S et al. (2006) Evolutionary history of Salmonella typhi. Science 314: 1301-1304. doi:https://doi.org/10.1126/science.1134933. PubMed: 17124322.
  10. 10. Holt KE, Parkhill J, Mazzoni CJ, Roumagnac P, Weill FX et al. (2008) High-throughput sequencing provides insights into genome variation and evolution in Salmonella Typhi. Nat Genet 40: 987-993. doi:https://doi.org/10.1038/ng.195. PubMed: 18660809.
  11. 11. Parkhill J, Dougan G, James KD, Thomson NR, Pickard D et al. (2001) Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18. Nature 413: 848-852. doi:https://doi.org/10.1038/35101607. PubMed: 11677608.
  12. 12. Holt KE, Thomson NR, Wain J, Langridge GC, Hasan R et al. (2009) Pseudogene accumulation in the evolutionary histories of Salmonella enterica serovars Paratyphi A and Typhi. BMC Genomics 10: 36. doi:https://doi.org/10.1186/1471-2164-10-S3-S36. PubMed: 19159446.
  13. 13. Pickard D, Wain J, Baker S, Line A, Chohan S et al. (2003) Composition, acquisition, and distribution of the Vi exopolysaccharide-encoding Salmonella enterica pathogenicity island SPI-7. J Bacteriol 185: 5055-5065. doi:https://doi.org/10.1128/JB.185.17.5055-5065.2003. PubMed: 12923078.
  14. 14. Tacket CO, Sztein MB, Losonsky GA, Wasserman SS, Nataro JP et al. (1997) Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans. Infect Immun 65: 452-456. PubMed: 9009296.
  15. 15. Jones PW, Collins P, Aitken MM (1988) Passive protection of calves against experimental infection with Salmonella typhimurium. Vet Rec 123: 536-541. doi:https://doi.org/10.1136/vr.123.21.536. PubMed: 3061151.
  16. 16. Hunter S, Apweiler R, Attwood TK, Bairoch A, Bateman A et al. (2009) InterPro: the integrative protein signature database. Nucleic Acids Res 37: D211-D215. doi:https://doi.org/10.1093/nar/gkn785. PubMed: 18940856.
  17. 17. Krogh A, Larsson B, von Heijne G, Sonnhammer EL (2001) Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol 305: 567-580. doi:https://doi.org/10.1006/jmbi.2000.4315. PubMed: 11152613.
  18. 18. Rutherford K, Parkhill J, Crook J, Horsnell T, Rice P et al. (2000) Artemis: sequence visualization and annotation. Bioinformatics 16: 944-945. doi:https://doi.org/10.1093/bioinformatics/16.10.944. PubMed: 11120685.
  19. 19. Hoiseth SK, Stocker BA (1981) Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291: 238-239. doi:https://doi.org/10.1038/291238a0. PubMed: 7015147.
  20. 20. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA et al. (2007) Clustal W and Clustal X version 2.0. Bioinformatics 23: 2947-2948. doi:https://doi.org/10.1093/bioinformatics/btm404. PubMed: 17846036.
  21. 21. Goujon M, McWilliam H, Li W, Valentin F, Squizzato S et al. (2010) A new bioinformatics analysis tools framework at EMBL-EBI. Nucleic Acids Res 38: W695-W699. doi:https://doi.org/10.1093/nar/gkq313. PubMed: 20439314.
  22. 22. Linehan SA, Rytkönen A, Yu XJ, Liu M, Holden DW (2005) SlyA regulates function of Salmonella pathogenicity island 2 (SPI-2) and expression of SPI-2-associated genes. Infect Immun 73: 4354-4362. doi:https://doi.org/10.1128/IAI.73.7.4354-4362.2005. PubMed: 15972530.
  23. 23. Kao KC, Yang YL, Boscolo R, Sabatti C, Roychowdhury V et al. (2004) Transcriptome-based determination of multiple transcription regulator activities in Escherichia coli by using network component analysis. Proc Natl Acad Sci U S A 101: 641-646. doi:https://doi.org/10.1073/pnas.0305287101. PubMed: 14694202.
  24. 24. Datsenko KA, Wanner BL (2000) One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97: 6640-6645. doi:https://doi.org/10.1073/pnas.120163297. PubMed: 10829079.
  25. 25. Chan W, Costantino N, Li R, Lee SC, Su Q et al. (2007) A recombineering based approach for high-throughput conditional knockout targeting vector construction. Nucleic Acids Res 35: e64. doi:https://doi.org/10.1093/nar/gkm163. PubMed: 17426124.
  26. 26. Deng W, Liou SR, Plunkett G 3rd, Mayhew GF, Rose DJ et al. (2003) Comparative genomics of Salmonella enterica serovar Typhi strains Ty2 and CT18. J Bacteriol 185: 2330-2337. doi:https://doi.org/10.1128/JB.185.7.2330-2337.2003. PubMed: 12644504.
  27. 27. Richardson EJ, Limaye B, Inamdar H, Datta A, Manjari KS et al. (2011) Genome sequences of Salmonella enterica serovar typhimurium, Choleraesuis, Dublin, and Gallinarum strains of well- defined virulence in food-producing animals. J Bacteriol 193: 3162-3163. doi:https://doi.org/10.1128/JB.00394-11. PubMed: 21478351.
  28. 28. Cherepanov PP, Wackernagel W (1995) Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant. Gene 158: 9-14. doi:https://doi.org/10.1016/0378-1119(95)00193-A. PubMed: 7789817.
  29. 29. Wang RF, Kushner SR (1991) Construction of versatile low-copy-number vectors for cloning, sequencing and gene expression in Escherichia coli. Gene 100: 195-199. doi:https://doi.org/10.1016/0378-1119(91)90366-J. PubMed: 2055470.
  30. 30. Uzzau S, Figueroa-Bossi N, Rubino S, Bossi L (2001) Epitope tagging of chromosomal genes in Salmonella. Proc Natl Acad Sci U S A 98: 15264-15269. doi:https://doi.org/10.1073/pnas.261348198. PubMed: 11742086.
  31. 31. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264. doi:https://doi.org/10.1093/biostatistics/4.2.249. PubMed: 12925520.
  32. 32. Smyth GK (2005) Limma: linear model for microarray data. R. GentlemanV. CareyS. DudoitRA IrizarryW. Huber. New York: Springer.
  33. 33. Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T). Methods - Nature Protocols 3: 1101-1108. doi:https://doi.org/10.1038/nprot.2008.73.
  34. 34. Winter SE, Thiennimitr P, Nuccio SP, Haneda T, Winter MG et al. (2009) Contribution of flagellin pattern recognition to intestinal inflammation during Salmonella enterica serotype typhimurium infection. Infect Immun 77: 1904-1916. doi:https://doi.org/10.1128/IAI.01341-08. PubMed: 19237529.
  35. 35. Rathman M, Sjaastad MD, Falkow S (1996) Acidification of phagosomes containing Salmonella typhimurium in murine macrophages. Infect Immun 64: 2765-2773. PubMed: 8698506.
  36. 36. Pickard D, Toribio AL, Petty NK, van Tonder A, Yu L et al. (2010) A conserved acetyl esterase domain targets diverse bacteriophages to the Vi capsular receptor of Salmonella enterica serovar Typhi. J Bacteriol 192: 5746-5754. doi:https://doi.org/10.1128/JB.00659-10. PubMed: 20817773.
  37. 37. MacLennan CA, Gondwe EN, Msefula CL, Kingsley RA, Thomson NR et al. (2008) The neglected role of antibody in protection against bacteremia caused by nontyphoidal strains of Salmonella in African children. J Clin Invest 118: 1553-1562. doi:https://doi.org/10.1172/JCI33998. PubMed: 18357343.
  38. 38. Kingsley RA, Humphries AD, Weening EH, De Zoete MR, Winter S et al. (2003) Molecular and phenotypic analysis of the CS54 island of Salmonella enterica serotype typhimurium: identification of intestinal colonization and persistence determinants. Infect Immun 71: 629-640. doi:https://doi.org/10.1128/IAI.71.2.629-640.2003. PubMed: 12540539.
  39. 39. Perkins TT, Davies MR, Klemm EJ, Rowley G, Wileman T et al. (2013) ChIP-seq and transcriptome analysis of the OmpR regulon of Salmonella enterica serovars Typhi and Typhimurium reveals accessory genes implicated in host colonization. Mol Microbiol 87: 526-538. doi:https://doi.org/10.1111/mmi.12111. PubMed: 23190111.
  40. 40. Abd El Ghany M, Jansen A, Clare S, Hall L, Pickard D et al. (2007) Candidate live, attenuated Salmonella enterica serotype Typhimurium vaccines with reduced fecal shedding are immunogenic and effective oral vaccines. Infect Immun 75: 1835-1842. doi:https://doi.org/10.1128/IAI.01655-06. PubMed: 17296764.
  41. 41. Barthel M, Hapfelmeier S, Quintanilla-Martínez L, Kremer M, Rohde M et al. (2003) Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infect Immun 71: 2839-2858. doi:https://doi.org/10.1128/IAI.71.5.2839-2858.2003. PubMed: 12704158.
  42. 42. Rad R, Brenner L, Bauer S, Schwendy S, Layland L et al. (2006) CD25+/Foxp3+ T cells regulate gastric inflammation and Helicobacter pylori colonization in vivo. Gastroenterology 131: 525-537. doi:https://doi.org/10.1053/j.gastro.2006.05.001. PubMed: 16890606.
  43. 43. Bochner BR, Gadzinski P, Panomitros E (2001) Phenotype microarrays for high-throughput phenotypic testing and assay of gene function. Genome Res 11: 1246-1255. doi:https://doi.org/10.1101/gr.186501. PubMed: 11435407.
  44. 44. Homann OR, Cai H, Becker JM, Lindquist SL (2005) Harnessing natural diversity to probe metabolic pathways. PLoS Genet 1: e80. doi:https://doi.org/10.1371/journal.pgen.0010080. PubMed: 16429164.
  45. 45. McFarland J (1907) Nephelometer: an instrument for estimating the number of bacteria in suspensions used for calculating the opsonic index and for vaccines. Journal of American Medical Association 49: 1176.
  46. 46. Kröger C, Dillon SC, Cameron AD, Papenfort K, Sivasankaran SK et al. (2012) The transcriptional landscape and small RNAs of Salmonella enterica serovar Typhimurium. Proc Natl Acad Sci U S A 109: E1277-E1286. doi:https://doi.org/10.1073/pnas.1201061109. PubMed: 22538806.
  47. 47. Ho YS, Burden LM, Hurley JH (2000) Structure of the GAF domain, a ubiquitous signaling motif and a new class of cyclic GMP receptor. EMBO J 19: 5288-5299. doi:https://doi.org/10.1093/emboj/19.20.5288. PubMed: 11032796.
  48. 48. Nikolskaya AN, Galperin MY (2002) A novel type of conserved DNA-binding domain in the transcriptional regulators of the AlgR/AgrA/LytR family. Nucleic Acids Res 30: 2453-2459. doi:https://doi.org/10.1093/nar/30.11.2453. PubMed: 12034833.
  49. 49. Hsing W, Silhavy TJ (1997) Function of conserved histidine-243 in phosphatase activity of EnvZ, the sensor for porin osmoregulation in Escherichia coli. J Bacteriol 179: 3729-3735. PubMed: 9171423.
  50. 50. Langridge GC, Phan MD, Turner DJ, Perkins TT, Parts L et al. (2009) Simultaneous assay of every Salmonella Typhi gene using one million transposon mutants. Genome Res 19: 2308-2316. doi:https://doi.org/10.1101/gr.097097.109. PubMed: 19826075.
  51. 51. Perkins TT, Kingsley RA, Fookes MC, Gardner PP, James KD et al. (2009) A Strand-Specific RNA–Seq Analysis of the Transcriptome of the Typhoid Bacillus Salmonella Typhi. PLOS Genet 5: 1-13.
  52. 52. Edgar R, Domrachev M, Lash AE (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30: 207-210. doi:https://doi.org/10.1093/nar/30.1.207. PubMed: 11752295.
  53. 53. Barrett T, Troup DB, Wilhite SE, Ledoux P, Evangelista C et al. (2011) NCBI GEO: archive for functional genomics data sets--10 years on. Nucleic Acids Res 39: D1005-D1010. doi:https://doi.org/10.1093/nar/gkq1184. PubMed: 21097893.
  54. 54. Finn RD, Mistry J, Tate J, Coggill P, Heger A et al. (2010) The Pfam protein families database. Nucleic Acids Res 38: D211-D222. doi:https://doi.org/10.1093/nar/gkp985. PubMed: 19920124.
  55. 55. Blum PH, Jovanovich SB, McCann MP, Schultz JE, Lesley SA et al. (1990) Cloning and in vivo and in vitro regulation of cyclic AMP-dependent carbon starvation genes from Escherichia coli. J Bacteriol 172: 3813-3820. PubMed: 2163388.
  56. 56. Khil PP, Obmolova G, Teplyakov A, Howard AJ, Gilliland GL et al. (2004) Crystal structure of the Escherichia coli YjiA protein suggests a GTP-dependent regulatory function. Proteins 54: 371-374. PubMed: 14696199.
  57. 57. Mirold S, Ehrbar K, Weissmüller A, Prager R, Tschäpe H et al. (2001) Salmonella host cell invasion emerged by acquisition of a mosaic of separate genetic elements, including Salmonella pathogenicity island 1 (SPI1), SPI5, and sopE2. J Bacteriol 183: 2348-2358. doi:https://doi.org/10.1128/JB.183.7.2348-2358.2001. PubMed: 11244077.
  58. 58. Maeba P, Sanwal BD (1969) Phosphoenolpyruvate carboxylase of Salmonella. Some chemical and allosteric properties. J Biol Chem 244: 2549-2557. PubMed: 4890227.
  59. 59. Kashket ER, Wilson TH (1969) Isolation and properties of mutants of Escherichia coli with increased phosphorylations of thiomethyl-beta-galactoside. Biochim Biophys Acta 193: 294-307. doi:https://doi.org/10.1016/0005-2736(69)90190-4. PubMed: 4900754.
  60. 60. Richardson AR, Soliven KC, Castor ME, Barnes PD, Libby SJ et al. (2009) The Base Excision Repair system of Salmonella enterica serovar typhimurium counteracts DNA damage by host nitric oxide. PLoS Pathog 5: e1000451. PubMed: 19478870.
  61. 61. Dizdaroglu M, Laval J, Boiteux S (1993) Substrate specificity of the Escherichia coli endonuclease III: excision of thymine- and cytosine-derived lesions in DNA produced by radiation-generated free radicals. Biochemistry 32: 12105-12111. doi:https://doi.org/10.1021/bi00096a022. PubMed: 8218289.
  62. 62. Schultz JE, Latter GI, Matin A (1988) Differential regulation by cyclic AMP of starvation protein synthesis in Escherichia coli. J Bacteriol 170: 3903-3909. PubMed: 2842291.
  63. 63. Schultz JE, Matin A (1991) Molecular and functional characterization of a carbon starvation gene of Escherichia coli. J Mol Biol 218: 129-140. doi:https://doi.org/10.1016/0022-2836(91)90879-B. PubMed: 1848300.
  64. 64. Dubey AK, Baker CS, Suzuki K, Jones AD, Pandit P et al. (2003) CsrA regulates translation of the Escherichia coli carbon starvation gene, cstA, by blocking ribosome access to the cstA transcript. J Bacteriol 185: 4450-4460. doi:https://doi.org/10.1128/JB.185.15.4450-4460.2003. PubMed: 12867454.
  65. 65. Noriega CE, Lin HY, Chen LL, Williams SB, Stewart V (2010) Asymmetric cross-regulation between the nitrate-responsive NarX-NarL and NarQ-NarP two-component regulatory systems from Escherichia coli K-12. Mol Microbiol 75: 394-412. doi:https://doi.org/10.1111/j.1365-2958.2009.06987.x. PubMed: 19968795.
  66. 66. Wanner BL (1992) Is cross regulation by phosphorylation of two-component response regulator proteins important in bacteria? J Bacteriol 174: 2053-2058. PubMed: 1551826.
  67. 67. Zhang H, Du H, Ji X, Ni B, Mao L et al. (2012) OmpR may regulate the putative YehU/YehT two-component system in Salmonella enterica serovar Typhi under hypotonic growth condition. Curr Microbiol 64: 283-289. doi:https://doi.org/10.1007/s00284-011-0066-3. PubMed: 22179129.
  68. 68. Perkins TT, Davies MR, Klemm EJ, Rowley G, Wileman T et al. (2013) ChIP-seq and transcriptome analysis of the OmpR regulon of Salmonella enterica serovars Typhi and Typhimurium reveals accessory genes implicated in host colonization. Mol Microbiol 87: 526-538. doi:https://doi.org/10.1111/mmi.12111. PubMed: 23190111.
  69. 69. Wolanin PM, Thomason PA, Stock JB (2002) Histidine protein kinases: key signal transducers outside the animal kingdom. Genome Biol 3: REVIEWS3013. PubMed: 12372152.